UroGen Pharma Ltd. Company | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

View All

Latest Posts

About This Stock More About This Stock
$10 Trillion Added In Market Cap; 2023’s Best And Worst Through July
Article By: Bespoke Investment Group
Tuesday, August 1, 2023 1:17 PM EDT
The US stock market has now seen an increase in market cap of roughly $10 trillion from its bear market low last October through the end of July 2023.
In this article: PLM, APLD, CVNA, URGN, RIOT, CIFR, QSI, RIVN
Read
Biotech Digest – URGN Receives Fast Track Designation, MDVX Receives Australian Approval, AZN Inks A New Deal
Article By: KKD Healthcare Analytics
Wednesday, August 30, 2017 12:45 PM EDT
UroGen Pharma announced that the FDA has designated its MitoGel for Fast Track review for the treatment of patients with low-grade upper urinary tract urothelial carcinoma. AstraZeneca inked a new deal with Takeda Pharmaceutical.
In this article: AZN, RNN, SGEN, ABEO, TRHC, URGN, MDVX, MBRX
Read
Argenx Joins Nasdaq Parade Following G1 Therapeutics With Another IPO Success
Article By: Lorimer Wilson
Thursday, May 18, 2017 5:45 PM EDT
Today's IPO by Argenx SE has proven to be a success as it was up 35% at the close of the trading day.Yesterday's IPO by G1 Therapeutics was also a success closing the day up 10.67% above its initial price.
In this article: ARGX Also: VRNA, ZYME, URGN, BHVN
Read
All Posts

Latest Tweets for $URGN

No tweets yet!

PARTNER HEADLINES